Jeffrey J. Quezada , Axs R. Avenido , Stephanie Jia , Arsanyous Bernaba , Sabrina Nguyen , Shayan S. Gharagozlou , Tan Q. Nguyen , Hari Keshava , Gelareh Sadigh
{"title":"Assessing Providers’ knowledge about and barriers to lung cancer screening","authors":"Jeffrey J. Quezada , Axs R. Avenido , Stephanie Jia , Arsanyous Bernaba , Sabrina Nguyen , Shayan S. Gharagozlou , Tan Q. Nguyen , Hari Keshava , Gelareh Sadigh","doi":"10.1016/j.ctarc.2024.100850","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><div>Low dose computed tomography (LDCT) for lung cancer screening (LCS) is underutilized despite its demonstrated mortality benefit compared to chest radiography. Our study aimed to assess knowledge about LCS and barriers to ordering LDCT from the viewpoint of primary care and pulmonology providers in academic and community settings.</div></div><div><h3>Methods</h3><div>Providers of various specialties (pulmonology, family medicine, internal medicine, geriatric medicine) who were practicing in Southern California and provided care to patients aged 50 or more were asked to complete a 10-minute survey to assess knowledge about LCS criteria, and barriers to the use of LDCT scan screening. Knowledge scores were calculated for each respondent based on their responses to 9 questions based on Centers for Medicare and Medicaid Services eligibility criteria with a total score range from 0 to 9 points.</div></div><div><h3>Results</h3><div>32 eligible providers completed the survey, of which none correctly identified all CMS eligibility criteria. Average knowledge score was 6.6 ± 1.1 and did not significantly differ based on practice setting, training level, or years of practice. Common barriers to utilization of LDCT included inaccurate smoking history in the medical record (56.2 %), failure of the medical record to notify providers of eligible patients (43.7 %), and concerns about financial cost of downstream tests after a positive scan (38.7 %).</div></div><div><h3>Conclusions</h3><div>Suboptimal provider knowledge of LDCT criteria may contribute to LCS underutilization. Improvement of educational resources for providers and augmentation of EMR smart tools to update documented smoking histories and notify providers of eligible patients may improve the rate of LCS.</div></div>","PeriodicalId":9507,"journal":{"name":"Cancer treatment and research communications","volume":"41 ","pages":"Article 100850"},"PeriodicalIF":0.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer treatment and research communications","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2468294224000625","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Objective
Low dose computed tomography (LDCT) for lung cancer screening (LCS) is underutilized despite its demonstrated mortality benefit compared to chest radiography. Our study aimed to assess knowledge about LCS and barriers to ordering LDCT from the viewpoint of primary care and pulmonology providers in academic and community settings.
Methods
Providers of various specialties (pulmonology, family medicine, internal medicine, geriatric medicine) who were practicing in Southern California and provided care to patients aged 50 or more were asked to complete a 10-minute survey to assess knowledge about LCS criteria, and barriers to the use of LDCT scan screening. Knowledge scores were calculated for each respondent based on their responses to 9 questions based on Centers for Medicare and Medicaid Services eligibility criteria with a total score range from 0 to 9 points.
Results
32 eligible providers completed the survey, of which none correctly identified all CMS eligibility criteria. Average knowledge score was 6.6 ± 1.1 and did not significantly differ based on practice setting, training level, or years of practice. Common barriers to utilization of LDCT included inaccurate smoking history in the medical record (56.2 %), failure of the medical record to notify providers of eligible patients (43.7 %), and concerns about financial cost of downstream tests after a positive scan (38.7 %).
Conclusions
Suboptimal provider knowledge of LDCT criteria may contribute to LCS underutilization. Improvement of educational resources for providers and augmentation of EMR smart tools to update documented smoking histories and notify providers of eligible patients may improve the rate of LCS.
期刊介绍:
Cancer Treatment and Research Communications is an international peer-reviewed publication dedicated to providing comprehensive basic, translational, and clinical oncology research. The journal is devoted to articles on detection, diagnosis, prevention, policy, and treatment of cancer and provides a global forum for the nurturing and development of future generations of oncology scientists. Cancer Treatment and Research Communications publishes comprehensive reviews and original studies describing various aspects of basic through clinical research of all tumor types. The journal also accepts clinical studies in oncology, with an emphasis on prospective early phase clinical trials. Specific areas of interest include basic, translational, and clinical research and mechanistic approaches; cancer biology; molecular carcinogenesis; genetics and genomics; stem cell and developmental biology; immunology; molecular and cellular oncology; systems biology; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; cancer policy; and integration of various approaches. Our mission is to be the premier source of relevant information through promoting excellence in research and facilitating the timely translation of that science to health care and clinical practice.